Only a few days to go: We’re raising £25,000 to keep TheyWorkForYou running and make sure people across the UK can hold their elected representatives to account.

Donate to our crowdfunder

NHS: Infectious Diseases

Health written question – answered on 21st May 2008.

Alert me about debates like this

Photo of Philip Davies Philip Davies Conservative, Shipley

To ask the Secretary of State for Health how many products were recommended to his Department by the Rapid Review Panel for (a) development for use in the NHS and (b) for trial in an NHS clinical setting in the last year for which information is available.

Photo of Ann Keen Ann Keen Parliamentary Under-Secretary (Health Services), Department of Health

The Rapid Review Panel (RRP) has reviewed 37 products in three meetings since May 2007.

Four products have demonstrated sufficient basic research and development, validation and recent in-use evaluations to enable the RRP to make a recommendation to the Department that the product should be made available to national health service bodies. This is a recommendation one.

Four products have been awarded a recommendation two stating that basic research and development has been completed and the product may have potential value; in use evaluations/trials are now needed in an NHS clinical setting. However, it is not within the remit of the RRP to clinically evaluate or undertake the evaluation of products within the NHS.

Does this answer the above question?

Yes1 person thinks so

No1 person thinks not

Would you like to ask a question like this yourself? Use our Freedom of Information site.